|
- Osteoboost - FDA-Cleared Vibration Therapy for Low Bone Density
Osteoboost uses vibration science originally developed for astronauts to counteract bone loss in space In a 12-month clinical trial, Osteoboost had no device-related serious adverse events Our innovative, patented technology provides targeted mechanical stimulation to where patients need it most
- The Osteoboost Promises to Slow Bone Loss—Heres How It Works
The medical technology innovator Osteoboost has just announced the release of a new FDA-cleared, holistic solution to treat osteopenia in postmenopausal women No drugs required—instead, you strap on a vibrating belt that looks like a fanny pack
- Osteoboost, a Wearable Device for Osteopenia Treatment, Now Available
Osteoboost, a targeted vibration therapy device, is now available to improve bone strength and bone density in postmenopausal women
- OsteoBoost: FDA-Cleared Vibration Belt Revolutionizes Osteopenia . . .
FDA has cleared OsteoBoost, developed by Bone Health Technologies, the first vibration belt shown to reduce loss of bone strength and density in postmenopausal women with osteopenia
- FRI681 Osteoboost Tm Is Effective In Preserving Bone Strength And . . .
Vibration has the potential to prevent bone loss and holds promise as an effective, yet minimal risk, treatment The Osteoboost, a novel wearable device delivering targeted vibration to the lumbar spine and hips, is designed to improve bone strength and bone density
- Shop Osteoboost | Clinically Proven Treatment for Low Bone Density
Osteoboost is a comfortable, wearable Class II medical device that delivers a precise, patented dose of mechanical stimulation to areas at highest risk of fracture—the spine and hips
- FDA-Cleared bone health device Osteoboost launches nationwide
Osteoboost is the first FDA-cleared device for low bone density, using vibration therapy to reduce bone loss in spine and hips Clinical trials showed significant reductions in bone density and strength loss, with no serious adverse events reported
- FDA clears Osteoboost wearable for treating low bone density
Osteoboost Health has announced the national availability of its newly FDA-cleared wearable device designed to treat low bone density – specifically osteopenia, a stage of bone thinning that precedes osteoporosis but which accounts for more than half of all fragility fractures
|
|
|